Trials / Completed
CompletedNCT07358403
Evaluation of the Dietary Supplement Efficacy Against Hair Loss in Subjects Suffering From Hair Loss
Clinical Instrumental Evaluation of the Efficacy of a Dietary Supplement Claiming Anti Hair Loss Properties
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Lacer S.A. · Industry
- Sex
- All
- Age
- 18 Years – 62 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study was to learn if dietary supplement in capsules and drinkable works to help hair loss in volunteers with chronic telogen effluvium and androgenetic alopecia and learn about its safety. The main questions it aims to answer are: * Does dietary supplement in capsules and drinkable reduces hair loss in women and men suffering from chronic telogen effluvium or androgenetic alopecia? * Were the products well accepted by the subjects from their´s perspective? Researchers will compare dietary supplement in capsules and drinkable to a placebo (a look-alike substance that contains no active ingredients) to see if dietary supplements works to reduce hair loss. Participants will: * Take assigned diatry supplement in capsule or drinkable or a placebo every day for 6 months * Visit the study facility once every 3 months for evaulations * Keep a diary of the product use
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Dietary supplement capsule use for hair loss | Dietary supplement capsule use for hair loss, once a day during 6 months. |
| DIETARY_SUPPLEMENT | Dietary supplement capsule placebo use for hair loss | Dietary supplement capsule placebo use for hair loss, once a day during 6 months. |
| DIETARY_SUPPLEMENT | Dietary supplement drinklable use for hair loss | Dietary supplement drinklable use for hair loss, once a day during 6 months. |
| DIETARY_SUPPLEMENT | Dietary supplement drinklable placebo | Dietary supplement drinklable placebo use for hair loss, once a day during 6 months. |
Timeline
- Start date
- 2024-11-04
- Primary completion
- 2025-09-26
- Completion
- 2025-09-26
- First posted
- 2026-01-22
- Last updated
- 2026-01-26
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07358403. Inclusion in this directory is not an endorsement.